RxDoctor Payments Data

Stephen Favrot, MD

Otolaryngology · Birmingham, ALNPI 1548393796

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 118 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $974, 2.9 times the $333 reported in 2019.

$3,602in general payments, 2019–2025

Across 118 payments — averaging $30.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Advanced Bionics, LLC$648
  • Inspire Medical Systems, Inc.$537
  • Stryker$391
  • GSK$365
  • Optinose US, Inc.$326
  • Sanofi$265
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,602100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,602 in reported general payments places this provider in the 75th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$138,758
Medicare patients
493
Services billed
2,071

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab11$40,672
Ipratropium Bromide122$5,105
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort93$4,806
Fluticasone Propionate291$4,711
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth22$2,875
Ofloxacin49$2,821
Omeprazole176$1,845
CefuroximeCefuroxime Axetil71$1,817
Potassium Chloride60$1,652
Mometasone Furoate82$1,414
Acetazolamide11$709
Azelastine Hcl18$473
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid76$425
Methylprednisolone32$331
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$319

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →